Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist: A Good Practices Report of an ISPOR Task Force

被引:6
作者
Fleurence, Rachael L. [1 ]
Kent, Seamus [2 ]
Adamson, Blythe [3 ]
Tcheng, James [4 ]
Balicer, Ran [5 ]
Ross, Joseph S. [6 ]
Haynes, Kevin [7 ]
Muller, Patrick [8 ]
Campbell, Jon [9 ]
Bouee-Benhamiche, Elsa [10 ]
Marti, Sebastian Garcia [1 ,11 ]
Ramsey, Scott [12 ]
机构
[1] Off Director, NIH, Bldg 1,9000 Rockville Pike, Bethesda, MD 20892 USA
[2] Erasmus Univ, Erasmus Sch Hlth & Policy Management, Rotterdam, Netherlands
[3] Flatiron Hlth, New York, NY USA
[4] Duke Univ, Durham, NC USA
[5] Clalit Hlth Serv, Tel Aviv, Israel
[6] Yale Univ, Yale Sch Med, New Haven, CT USA
[7] Janssen Res & Dev, Titusville, NJ USA
[8] Natl Inst Hlth & Care Excellence, Ctr Guidelines, London, England
[9] Natl Pharmaceut Council, Washington, DC USA
[10] Inst Natl Canc, Publ Hlth & Healthcare Div, Boulogne Billancourt, France
[11] Inst Clin Effectiveness & Hlth Policy, Hlth Technol Assessment & Hlth Econ Dept, Buenos Aires, Argentina
[12] Fred Hutchinson Canc Ctr, Hutchinson Inst Canc Outcomes Res, 100 Fairview Ave N, Seattle, WA 98109 USA
关键词
data quality; electronic health records; health technology assessment; real-world data; real-world evidence; QUALITY;
D O I
10.1016/j.jval.2024.01.019
中图分类号
F [经济];
学科分类号
02 ;
摘要
This ISPOR Good Practices report provides a framework for assessing the suitability of electronic health records data for use in health technology assessments (HTAs). Although electronic health record (EHR) data can fill evidence gaps and improve decisions, several important limitations can affect its validity and relevance. The ISPOR framework includes 2 components: data delineation and data fitness for purpose. Data delineation provides a complete understanding of the data and an assessment of its trustworthiness by describing (1) data characteristics; (2) data provenance; and (3) data governance. Fitness for purpose comprises (1) data reliability items, ie, how accurate and complete the estimates are for answering the question at hand and (2) data relevance items, which assess how well the data are suited to answer the particular question from a decision making perspective. The report includes a checklist specific to EHR data reporting: the ISPOR SUITABILITY Checklist. It also provides recommendations for HTA agencies and policy makers to improve the use of EHR-derived data over time. The report concludes with a discussion of limitations and future directions in the field, including the potential impact from the substantial and rapid advances in the diffusion and capabilities of large language models and generative artificial intelligence. The report 's immediate audiences are HTA evidence developers and users. We anticipate that it will also be useful to other stakeholders, particularly regulators and manufacturers, in the future.
引用
收藏
页码:692 / 701
页数:10
相关论文
共 50 条
  • [21] Best (but often forgotten) Statistical Practices: Measuring Real-World Intervention Effectiveness using Electronic Health Data
    Wolfson, Julian
    Venkatasubramaniam, Ashwini
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 2023, 118 (01) : 13 - 22
  • [22] Assessing the suitability of general practice electronic health records for clinical prediction model development: a data quality assessment
    Thuraisingam, Sharmala
    Chondros, Patty
    Dowsey, Michelle M.
    Spelman, Tim
    Garies, Stephanie
    Choong, Peter F.
    Gunn, Jane
    Manski-Nankervis, Jo-Anne
    BMC MEDICAL INFORMATICS AND DECISION MAKING, 2021, 21 (01)
  • [23] Real-world data: a comprehensive literature review on the barriers, challenges, and opportunities associated with their inclusion in the health technology assessment process
    Zisis, Konstantinos
    Pavi, Elpida
    Geitona, Mary
    Athanasakis, Kostas
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2024, 27
  • [24] Why is target trial emulation not being used in health technology assessment real-world data submissions?
    Castanon, Alejandra
    Duffield, Stephen
    Ramagopalan, Sreeram
    Reynolds, Robert
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (08)
  • [25] Population pharmacokinetic analysis of dexmedetomidine in children using real-world data from electronic health records and remnant specimens
    James, Nathan T.
    Breeyear, Joseph H.
    Caprioli, Richard
    Edwards, Todd
    Hachey, Brian
    Kannankeril, Prince J.
    Keaton, Jacob M.
    Marshall, Matthew D.
    Van Driest, Sara L.
    Choi, Leena
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (06) : 2885 - 2898
  • [26] Why is target trial emulation not being used in health technology assessment real-world data submissions?
    Castanon, Alejandra
    Duffield, Stephen
    Ramagopalan, Sreeram
    Reynolds, Robert
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024,
  • [27] Emulating Target Trials With Real-World Data to Inform Health Technology Assessment: Findings and Lessons From an Application to Emergency Surgery
    Moler-Zapata, Silvia
    Hutchings, Andrew
    O'Neill, Stephen
    Silverwood, Richard J.
    Grieve, Richard
    VALUE IN HEALTH, 2023, 26 (08) : 1164 - 1174
  • [28] Policies for Use of Real-World Data in Health Technology Assessment (HTA): A Comparative Study of Six HTA Agencies
    Makady, Amr
    ten Ham, Renske
    de Boer, Anthonius
    Hillege, Hans
    Klungel, Olaf
    Goettsch, Wim
    VALUE IN HEALTH, 2017, 20 (04) : 520 - 532
  • [29] Generate Analysis-Ready Data for Real-world Evidence: Tutorial for Harnessing Electronic Health Records With Advanced Informatic Technologies
    Hou, Jue
    Zhao, Rachel
    Gronsbell, Jessica
    Lin, Yucong
    Bonzel, Clara-Lea
    Zeng, Qingyi
    Zhang, Sinian
    Beaulieu-Jones, Brett K.
    Weber, Griffin M.
    Jemielita, Thomas
    Wan, Shuyan Sabrina
    Hong, Chuan
    Cai, Tianrun
    Wen, Jun
    Panickan, Vidul Ayakulangara
    Liaw, Kai-Li
    Liao, Katherine
    Cai, Tianxi
    JOURNAL OF MEDICAL INTERNET RESEARCH, 2023, 25
  • [30] Real-world data and evidence in health technology assessment: When are they complementary, substitutes, or the only sources of data compared to clinical trials?
    de Pouvourville, Gerard
    Armoiry, Xavier
    Lavorel, Aurelie
    Bilbault, Pascal
    Maugendre, Philippe
    Bensimon, Lionel
    Beziz, Dan
    Blin, Patrick
    Borget, Isabelle
    Bouee, Stephane
    Collignon, Cecile
    Dervaux, Benoit
    Durand-Zaleski, Isabelle
    Julien, Marc
    de Leotoing, Lucie
    Majed, Laureen
    Martelli, Nicolas
    Sejourne, Thomas
    Viprey, Marie
    THERAPIE, 2023, 78 (01): : 81 - 94